Angiotensin II (A-II) produces contraction of isolated vascular smooth muscle preparations obtained from rat, guineapig, rabbit and other animals, but reports about effects of A-II on amphibian vascular smooth muscles are lacking. In this study the effects of A-II and its antagonists saralasin and losartan were studied on isolated frog aortic strips. 
INTRODUCTION
Various vascular smooth muscle preparations like rat aorta, rabbit aorta, cat aorta, cat basilar artery, pig coronary artery, dog aorta, dog coronary artery, goat cerebral artery and guinea-pig basilar artery are commonly used for study of some cardiovascular drugs. Compared to these animals frogs are easy to handle and their maintenance is also cost effective.
It is now well established that renin angotensin system (RAS) plays an important role in pathogenesis of hypertension, congestive heart failure and renal failure. There are plenty of reports regarding effect of angiotensin II (A-II) on rat aorta and various mammalian vascular smooth muscle preparations but reports about the effect of A-II on amphibian vascular smooth muscle are lacking. Frog aorta is highly sensitive to A-II. Tachyphylaxis was a less problem compared to rabbit and cat aortic strips. A 30 min cycle for submaximal contractile responses to A-II could be effectively maintained for eight to ten hours without appreciable change in sensitivity.
A-II responses could not be blocked by antagonists like prazosin, propranolol or atropine indicating high specificity. Other agonists like noradrenaline, adrenaline, acetylcholine, histamine and 5-hydroxytryptamine also produced contractile responses but high concentrations of these agonists were required to elicit contractile responses.
MATERIALS AND METHODS
This work was carried out in 1998-99. There was no existence of the institutional animal ethics committee during this study period. Hence we are unable to provide statement regarding ethical approval.
Aortic strip preparation
Frog (Rana Tigrina) was sacrificed on the day of experiment and was fixed on a corkboard. The thoracic cavity was opened. The two lateral aortae emerging from the truncus arteriosus were dissected free from surrounding tissues and were placed in a petri-dish containing oxygenated frog ringer. Frog aorta contains two septums, which divide aorta in to three divisions. The two aortae were separated, cleaned well and cut spirally by the method of Furchgott and Bhadrakom. [1] Iris scissor was used to cut aorta spirally and making a strip. Two strips were obtained, measuring about 1.5 mm in width and 2.0-2.5 cm in length. Experiments were done on both strips simultaneously. Two threads were sewn; one at each end and this amphibian tissue preparation was mounted in a 5 ml organ bath filled with Frog-Ringer's solution, bathed with oxygen at room temperature (22
• -30 • C). One end was attached to fixed pin in the organ bath and the other end to a previously balanced frontal writing simple lever with a 10 fold magnification. A resting tension of 0.5 g was applied and the tissue was allowed to relax for one h before addition of drugs. Responses were recorded on smoked kymograph paper.
Drugs
Angiotensin-II (Sigma Chemicals Company, USA), saralasin (Sigma Chemicals Company, USA) and losartan (Unichem Laboratory, India) were used.
Statistical analysis
Values are expressed in mean ± SE. Statistical analysis was done by using Student's unpaired t-test. P < 0.05 was considered statistically significant.
RESULTS
Frog aortic strip was stable for long time. The onset of contractile response was about 30 s after addition of the A-II.
Sensitivity of A-II was somewhat more in frog aorta (9.56 × 10 -12 M) compared to rabbit (4.78 × 10 -11 M) and cat aorta (2.39 × 10 -11 M). [2] There was a clearcut distinction between the phasic and tonic components of the contractile response, the phasic component lasting about 40% of the total time duration. Frog aorta took 30 min for relaxation.
To establish a dose response curve of A-II on frog aorta was difficult because of tachyphylaxis. As frog aorta was a new preparation to be studied in our laboratory cumulative dose response curve (CDRC) of A-II using 9.56 × 10
-12 M to 6.69 × 10 -9 M concentration and keeping 60 min to 120 min time interval between two successive CDRCs was recorded. For comparison with rabbit aorta, CDRC of A-II was recorded in rabbit aorta also. [2] An attempt was made to obtain Schild's plot to determine pA 2 value for saralasin and losartan. In frog aorta, to antagonize the responses of A-II, 100 to 250 times higher doses of saralasin were required as compared to rabbit aorta.
Saralasin:
CDRCs of A-II were recorded in absence and presence of different concentrations of saralasin [ Table 1 -6 M saralasin E max/2 was 6.6 × 10 -11 M, so dose ratio at 5.48 × 10 -6 M saralasin was 2.40. Negative log of molar concentration of A-II was taken on abscissa and log (X-1) of A-II was taken on ordinate and a graph was plotted. From graph pA 2 value was to be 5.48 [ Figure 2 ].
Losartan:
As eliciting CDRC of A-II was time consuming and there was a problem of tachyphylaxis, effect of losartan was studied on a submaximal response M losartan E max/2 was 7.41 × 10 -11 M and dose ratio was 4.13 (not shown in figures). From the graph an extrapolation pA 2 value was found to be 12.02 [ Figure 4 ].
In some experiments losartan itself produced contractile response. The mean height of the response produced by losartan 4.32 × 10 -11 M, 1.29 × 10 -10 M and 4.32 × 10 -10 M was 8.6mm, 15.25mm and 9.25mm respectively. Higher doses of losartan do not produce maximum response. Losartan was 2.5 times less potent compared to A-II to produce contraction of frog aorta. The mean height of the losartan 4.32 × 10 -10 M response compared with A-II 1.52 × 10 -11 M was 64.05%.
DISCUSSION
For study of vascular smooth muscles, various mammalian preparations like rat aorta and rabbit aorta are very commonly used. Similarly for assessment of RAS, same preparations are used. In the present study, we used frog aorta for study of action of A-II. We found this amphibian preparation quite suitable tool for assessment of actions and mechanisms of action A-II. It seems to be a promising preparation for study of RAS.
Frog aorta was found to be highly sensitive to A-II. A submaximal response was obtained with 9.56 × 10 -12 M A-II and Emax/2 was 2.69 × 10 -11 M. Tachyphylaxis is always observed in vascular smooth muscle preparations and particularly when A-II is used as an agonist. Time interval between two successive contractions in frog aorta was 30 min, which is comparatively more in rabbit aorta (45 min) and cat aorta (90 min). [2] Effect of A-II antagonists saralasin and losartan were studied on frog aorta. In 1977 Peach suggests that saralasin blocks responses to A-II in a competitive manner. But reports of subsequent studies were somewhat different. [3] Chiu et al suggests that saralasin displays a non-competitive type of antagonism against A-II induced vasoconstriction in the rabbit aorta and gave a pA 2 value of 9.47 and a slope of 0.68. [4] Wong et al showed that in pithed rat saralasin shifted the dose pressure response curve for A-II to the right in a non-parallel fashion and depressed the maximal response to A-II suggesting non-competitive A-II antagonism. [5] Freer et al observed that in rabbit aorta saralasin at low concentrations, shifts the A-II concentration-response curve in a parallel manner to the right but with increasing concentrations it reduces the slope and maximum response. Although numerous speculations on the non-competitive nature of the antagonism have been advanced, the exact mechanism remains unresolved. [6] In our study, we found that in rabbit aortic strip, saralasin in concentrations of 5 [2] In frog aorta we tested three graded concentrations of saralasin. Saralasin in concentrations of 5.48 × 10 -7 M, 1.64 × 10 -6 M and 5.48 × 10 -6 M shifted DRC of A-II to the right in a non-parallel manner but maximal response was not affected. pA 2 value was found to be 5.48 with Schild plot having a slope of 0.57 [7] indicating non-competitive type of antagonism.
Saralasin is about 10 fold more potent than losartan. [6] Losartan binds with higher affinity and specifically to the AT 1 receptors than for the AT 2 receptors. Losartan was shown to inhibit the specific binding of labelled A-II to its receptor sites in various experimental models like rat and rabbit aortic strips. [8] Chiu et al demonstrated that in rabbit aorta losartan shifted concentration-contractile response curve to A-II to the right in a parallel Losartan was found to be more potent nonpeptide analogue exhibiting a pA 2 value of 8.84 with a slope of 0.97. [9] Graded concentrations of losartan i.e., 1 We attempted to plot a dose response curve to A-II by using submaximal and another near to maximal concentrations of A-II. For losartan pA 2 value was found to be 12.02 with Schild plot having a slope of 1.7 [7] indicating competitive type of antagonism. Our study suggests that a frog aortic strip is a good experimental preparation for the study of A-II responses and local RAS as well as to find out receptor antagonism for various agonists acting on vascular smooth muscles.
